These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 15726582

  • 21. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
    Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y.
    Ann Neurol; 1990 Jun; 27(6):676-82. PubMed ID: 2360804
    [Abstract] [Full Text] [Related]

  • 22. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice.
    Short JL, Ledent C, Borrelli E, Drago J, Lawrence AJ.
    Neuroscience; 2006 May 12; 139(2):661-70. PubMed ID: 16476524
    [Abstract] [Full Text] [Related]

  • 23. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.
    Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ.
    Exp Neurol; 1991 Oct 12; 114(1):73-81. PubMed ID: 1915737
    [Abstract] [Full Text] [Related]

  • 24. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
    Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ.
    Ann Neurol; 2007 Nov 12; 62(5):468-74. PubMed ID: 17886297
    [Abstract] [Full Text] [Related]

  • 25. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M, Kondo T, Mizuno Y, Nagatsu T.
    Neurosci Lett; 2007 Feb 27; 414(1):94-7. PubMed ID: 17196747
    [Abstract] [Full Text] [Related]

  • 26. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
    Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O.
    Neurology; 2008 Apr 15; 70(16 Pt 2):1403-10. PubMed ID: 18172064
    [Abstract] [Full Text] [Related]

  • 27. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease.
    Uhl GR.
    Ann Neurol; 1998 May 15; 43(5):555-60. PubMed ID: 9585349
    [No Abstract] [Full Text] [Related]

  • 28. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 29. Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease.
    Lo HS, Chiang HC, Lin AM, Chiang HY, Chu YC, Kao LS.
    Neurobiol Dis; 2004 Oct 24; 17(1):54-61. PubMed ID: 15350965
    [Abstract] [Full Text] [Related]

  • 30. Immunochemical analysis of dopamine transporter protein in Parkinson's disease.
    Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI.
    Ann Neurol; 1997 Apr 24; 41(4):530-9. PubMed ID: 9124811
    [Abstract] [Full Text] [Related]

  • 31. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK.
    J Pharmacol Exp Ther; 2005 Aug 24; 314(2):575-83. PubMed ID: 15879005
    [Abstract] [Full Text] [Related]

  • 32. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.
    Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P.
    Eur J Neurosci; 2005 Feb 24; 21(4):841-54. PubMed ID: 15787691
    [Abstract] [Full Text] [Related]

  • 33. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc.
    Stanic D, Parish CL, Zhu WM, Krstew EV, Lawrence AJ, Drago J, Finkelstein DI, Horne MK.
    J Neurochem; 2003 Jul 24; 86(2):329-43. PubMed ID: 12871574
    [Abstract] [Full Text] [Related]

  • 34. Elevated NMDA receptors in parkinsonian striatum.
    Weihmuller FB, Ulas J, Nguyen L, Cotman CW, Marshall JF.
    Neuroreport; 1992 Nov 24; 3(11):977-80. PubMed ID: 1482768
    [Abstract] [Full Text] [Related]

  • 35. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H, Doenlen R, Riether C, Engler A, Niemi MB, Besedovsky HO, del Rey A, Pacheco-López G, Feldon J, Schedlowski M.
    Brain Behav Immun; 2009 May 24; 23(4):518-26. PubMed ID: 19486644
    [Abstract] [Full Text] [Related]

  • 36. Striatal dopaminergic neurons are lost with Parkinson's disease progression.
    Porritt MJ, Kingsbury AE, Hughes AJ, Howells DW.
    Mov Disord; 2006 Dec 24; 21(12):2208-11. PubMed ID: 17029264
    [Abstract] [Full Text] [Related]

  • 37. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.
    Uhl GR.
    Mov Disord; 2003 Oct 24; 18 Suppl 7():S71-80. PubMed ID: 14531049
    [Abstract] [Full Text] [Related]

  • 38. Regulation of dopaminergic activity in early Parkinson's disease.
    Tedroff J, Ekesbo A, Rydin E, Långström B, Hagberg G.
    Ann Neurol; 1999 Sep 24; 46(3):359-65. PubMed ID: 10482266
    [Abstract] [Full Text] [Related]

  • 39. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A.
    Neurochem Int; 2006 Apr 24; 48(5):329-40. PubMed ID: 16406146
    [Abstract] [Full Text] [Related]

  • 40. Evidence of a breakdown of corticostriatal connections in Parkinson's disease.
    Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA.
    Neuroscience; 2005 Apr 24; 132(3):741-54. PubMed ID: 15837135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.